MRPS16 and ovarian carcinoma: (2021) examined the expression of six MRPs in a variety of ovarian cancer datasets, including TCGA, GTEx (Genotype-Expression Tissue Portal), and Oncomine, and found a strong positive correlation between increased MRPS16 and poor survival in ovarian cancer [26].